{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:08:32Z","timestamp":1773799712126,"version":"3.50.1"},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1669","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>Epsolay (Galderma), a 5% benzoyl peroxide cream, has been approved by the FDA for treatment of inflammatory lesions of rosacea in adults.<\/jats:p>","DOI":"10.58347\/tml.2023.1669c","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T21:22:18Z","timestamp":1676409738000},"page":"21-22","source":"Crossref","is-referenced-by-count":1,"title":["Epsolay - A Benzoyl Peroxide Cream for Rosacea"],"prefix":"10.58347","volume":"65","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2023,2,6]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T21:22:20Z","timestamp":1676409740000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1669c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":0,"journal-issue":{"issue":"1669","published-online":{"date-parts":[[2023,2,6]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2023.1669c","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]}}}